Chris Calhoun CEO of Cytori Therapeutics, Inc.,
Rings The NASDAQ Stock Market Closing Bell

Monday, February 13, 2006
at NASDAQ's MarketSite
in New York City.

Cytori Therapeutics, Inc.

Chris Calhoun CEO of Cytori Therapeutics, Inc., presides over the closing bell to celebrate its listing on the NASDAQ. Cytori Therapeutics, Inc., (NASDAQ: CYTX); (Frankfurt: XMPA) is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat. The Company's preclinical investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders and new approaches for aesthetic and reconstructive surgery.

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 2/14/2006 Download Hi-Res Quality Photo of this NASDAQ Market Close - Pictured: Chris Calhoun CEO of Cytori Therapeutics, Inc. rings the Closing Bell. These photos are Copyright 2006, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2006, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.